Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-11-047136)

Filing Details

Accession Number:: 0001209191-11-047136
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-09-08 16:53:01
Reporting Period:: 2011-09-07

Filing Date:: 2011-09-08
Accepted Time:: 2011-09-08 16:53:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1009356	Salix Pharmaceuticals Ltd	SLXP	Pharmaceutical Preparations (2834)	943267443

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1053880	F John Chappell	8510 Colonnade Center Drive Raleigh NC 27615		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-09-07	1,360	$29.55	536,244	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	16,000	Indirect	By Spouse

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Option to Buy Common Stock	$17.63		2015-06-09	15,000	15,000	Direct
Common Stock	Option to Buy Common Stock	$18.87		2014-06-17	22,500	22,500	Direct
Common Stock	Option to Buy Common Stock	$7.60		2013-07-24	15,000	15,000	Direct
Common Stock	Option to Buy Common Stock	$4.07		2012-07-02	15,000	15,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2015-06-09	15,000	15,000	Direct
2014-06-17	22,500	22,500	Direct
2013-07-24	15,000	15,000	Direct
2012-07-02	15,000	15,000	Direct

Footnotes

Options are 100% vested.